Publication Archive: Ohio Opioid Lawyers

Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway over it’s suggesting to settle the opioid lawsuits against it will likely cost the company a fraction of that figure, according to industry experts. When Teva announced the value of the donated medicine – a generic version of opioid addiction treatment Suboxone – it based the…Read the article

As opening statements were about to be made Monday morning in the first Cleveland Federal Court trial in the Nationwide Opioid litigation brought on behalf of more than 2000 cities in counties against drug manufacturers, distributors, and retail pharmacy chains, the bellwether plaintiffs (Cuyahoga and Summit County, Ohio) announced a settlement with McKesson, Amerisource Bergan,…Read the article

Teva Pharmaceutical Industries Ltd’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts. In interviews with Reuters, lawyers representing local governments in the…Read the article

Following a major settlement in Ohio this week, California counties could be a step closer to getting the drug industry to pay for damages associated with the opioid epidemic. The nation’s three biggest drug distributors and a major drugmaker reached an 11th-hour, $260 million settlement over the toll of the opioids in two Ohio counties,…Read the article

Lead lawyer for Cuyahoga County Hunter J. Shkolnik, partner at Napoli Shkolnik of New York City, said the funds from the case will be used entirely for treatment. “What’s significant is we have brought to Cuyahoga County and my co-counsel with respect to Summit County money now, significant money now, and also it set a…Read the article

When Teva announced the value of the donated medicine, a generic version of opioid addiction treatment Suboxone, it based the figure on the drug’s list price, which does not account for significant discounts routinely provided by the drugmaker. If based on the estimated cost to manufacture the drugs, the value could be as low as…Read the article

In interviews with Reuters, lawyers representing local governments in the opioid litigation said the figure proposed by Teva inflates the real value of the drugs. They said the proposal will not be enough to address a nationwide addiction crisis that has claimed some 400,000 lives over the last two decades. The deal is “overvalued to…Read the article

J&J, Teva offer a massive $48B combined to wrap opioid suits, but not all plaintiffs are on board With reports like that in the ether, it’s no wonder some plaintiffs are reticent to sign on to the “framework deal” that includes the Teva and J&J offers, along with additional deals with three drug distributors. Officials in at least four…Read the article

In interviews with Reuters, lawyers representing local governments in the opioid litigation said the figure proposed by Teva inflates the real value of the drugs. They said the proposal will not be enough to address a nationwide addiction crisis that has claimed some 400,000 lives over the last two decades. The deal is “overvalued to…Read the article

While the nation’s first federal opioid trial ended Monday without an actual trial, the cases drug companies face nationwide are far from over. Attorneys representing the thousands cities and counties in federal court said they intend to pursue their other cases and that negotiations should continue. After talks broke down on Friday with state attorneys…Read the article